Literature DB >> 7504537

Purification of an active TATA-binding protein-containing factor using a monoclonal antibody that recognizes the human TATA-binding protein.

P K Chatterjee1, R Pruzan, S J Flint.   

Abstract

The human TATA-binding protein was expressed in Escherichia coli as a fusion with an N-terminal hexahistidine sequence, partially purified, and used to raise monoclonal antibodies. More than 50 hybridoma clones producing antibodies that reacted in immunoblot assays with HeLa cell TATA-binding protein and its bacterially synthesized derivative were identified. All antibodies examined recognized epitopes within the N-terminal 159 amino acids of the human TATA-binding protein. Further characterization of one monoclonal antibody, MTBP-6, established that it immunoprecipitates both native HeLa cell TATA-binding protein and TATA-binding protein extracted from cells in the presence of 0.5% SDS. Antibody MTBP-6 immunoprecipitates of native, human cell TATA-binding protein contained the TATA-binding protein and additional polypeptides. Immunoprecipitation of both the TATA-binding protein and several additional polypeptides was specifically blocked by bacterially synthesized, hexahistidine-tagged TATA-binding protein, suggesting that MTBP-6 can efficiently recognize the TATA-binding protein in TFIID and other complexes. Consistent with this conclusion, immunoaffinity chromatography on antibody MTBP-6 permitted purification, in active form, of a TATA-binding protein-containing factor required for transcription by RNA polymerase III. These properties suggest that MTBP-6 will be a useful reagent for the purification and characterization of the multiple TBP-containing complexes present in human cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504537     DOI: 10.1006/prep.1993.1059

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Functional interchangeability of TFIIIB components from yeast and human cells in vitro.

Authors:  M Teichmann; G Dieci; J Huet; J Rüth; A Sentenac; K H Seifart
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

2.  Nucleolin is required for RNA polymerase I transcription in vivo.

Authors:  Brenden Rickards; S J Flint; Michael D Cole; Gary LeRoy
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

3.  Using BAC transgenesis in zebrafish to identify regulatory sequences of the amyloid precursor protein gene in humans.

Authors:  Leighcraft A Shakes; Hansen Du; Hope M Wolf; Charles Hatcher; Derek C Norford; Patricia Precht; Ranjan Sen; Pradeep K Chatterjee
Journal:  BMC Genomics       Date:  2012-09-04       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.